Venglustat clinical trials
Also written GZ/SAR402671 and Genz-682452.
How each study uses venglustat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the venglustat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
17 studies that test it; most in 2020 (4)
| Year | Studies |
|---|---|
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 17 · Other 0
Studies
Open first, then newest update. How each study uses venglustat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 17
- The Efficacy and Safety of Venglustat Compared With Cerezyme in Pediatric Participants 2 to 11 Years of Age With Gaucher Disease Type 3 (GD3)Not yet recruitingPhase 3SanofiNCT07927140Written as Venglustat
- A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry DiseaseActive, not recruitingPhase 3SanofiNCT05206773Written as Venglustat (GZ402671)
- Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3Active, not recruitingPhase 3SanofiNCT05222906Written as Venglustat
- Venglustat in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3 With Venglustat Monotherapy ExtensionActive, not recruitingPhase 2Genzyme, a Sanofi CompanyNCT02843035Written as venglustat (GZ402671)
- A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry DiseaseActive, not recruitingPhase 3SanofiNCT05280548Written as Venglustat (GZ402671)
- A Multinational, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Pharmacodynamics, Pharmacokinetics, and Safety of Venglustat in Late-onset GM2TerminatedPhase 3Genzyme, a Sanofi CompanyNCT04221451Written as venglustat GZ402671
- Excretion Balance, Pharmacokinetics, and Metabolism Following of [14C]-Venglustat Administration in Healthy Male SubjectsCompletedPhase 1Genzyme, a Sanofi CompanyNCT05238714Written as venglustat
- Long-term Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) With VenglustatTerminatedPhase 3SanofiNCT04705051Written as Venglustat GZ402671
- A Study in Adults to Investigate the Impact of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Venglustat Compared to Participants With Normal Hepatic FunctionCompletedPhase 1SanofiNCT05718258Written as Venglustat (GZ402671)
- A Study of the Safety, Tolerability, and Pharmacokinetics of Orally Administered Venglustat and Itraconazole in Healthy Adult Male ParticipantsCompletedPhase 1Genzyme, a Sanofi CompanyNCT06421714Written as Venglustat
- A Study of the Safety, Tolerability, and Bioavailability of Orally Administered Venglustat in Healthy Adult ParticipantsCompletedPhase 1SanofiNCT06418620Written as Venglustat
- A Study of the Safety, Tolerability, and Bioequivalence of Orally Administered Venglustat in Healthy Adult ParticipantsCompletedPhase 1SanofiNCT06418607Written as Venglustat
- A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD PatientsTerminatedPhase 2/3Genzyme, a Sanofi CompanyNCT03523728Written as Venglustat
- Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry DiseaseCompletedPhase 2Genzyme, a Sanofi CompanyNCT02489344Written as GZ/SAR402671
- Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-naïve Adult Male Patients With Fabry DiseaseCompletedPhase 2Genzyme, a Sanofi CompanyNCT02228460Written as GZ/SAR402671
- A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of Genz-682452 in Healthy VolunteersCompletedPhase 1Genzyme, a Sanofi CompanyNCT01710826Written as Genz-682452
- Safety, Tolerability and Pharmacokinetics of Genz-682452 in Healthy MenCompletedPhase 1Genzyme, a Sanofi CompanyNCT01674036Written as Genz-682452
What changed recently
From the registry's own updates since Oct 18, 2026.
Newly registered1
Codes
What other systems call venglustat · ClinicalTrials.gg INT000468
- MeSH (NLM) C000608118venglustatConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) BLP1XA3FZAVENGLUSTATConfirmed FDA, NLM, Wikidata
- Wikidata Q27274745venglustatConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152852VenglustatOne source FDA
- DrugBank DB14966One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000608118 | venglustat | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | BLP1XA3FZA | VENGLUSTAT | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27274745 | venglustat | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152852 | Venglustat | One source FDA |
| DrugBank | DB14966 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.